Amiodarone before electrical cardioversion for persistent atrial fibrillation
Treatments studied
Part of Heart & circulation clinical trials.
This study tests whether giving the medicine amiodarone before a scheduled electrical cardioversion (a procedure that shocks the heart back into rhythm) improves the chances of restoring a normal heartbeat in people with persistent atrial fibrillation. It compares outcomes with and without this pre-treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You have persistent atrial fibrillation, meaning your irregular heartbeat has lasted at least 7 days.
- You are already scheduled to have an electrical cardioversion (a procedure that uses a shock to restore normal heart rhythm).
- You are not taking certain heart rhythm medications (like amiodarone) in the days leading up to the procedure.
- You do not have severe heart failure, very weak heart pumping, or significant thyroid or liver disease.
- You have no allergy to the study drug and are willing to use birth control if you could become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a procedure called electrical cardioversion (a controlled shock to reset your heart rhythm) can help explain and possibly improve symptoms of atrial fibrillation and heart failure. If you qualify, you'll receive this procedure and your symptoms will be closely monitored.
This study tests whether giving amiodarone both through an IV and as a pill, compared to just the pill, can better prevent atrial fibrillation from coming back after your first catheter ablation. The goal is to help you stay in a normal heart rhythm for longer.
This study tests whether doing a short cycling exercise right before a heart shock procedure (called electrical cardioversion) can make the procedure more effective at restoring a normal heartbeat. If successful, it could simplify treatment for people with persistent atrial fibrillation.
This trial tests two different ways of taking amiodarone (a heart rhythm medicine) to keep your heart in a normal rhythm after a procedure called electrical cardioversion. It's designed for people with persistent atrial fibrillation (a fast, irregular heartbeat lasting at least 7 days).
This study tests a stepwise treatment plan for people with persistent atrial fibrillation (a long-lasting irregular heartbeat) who also have an enlarged left atrium. It aims to see if a medication called amiodarone plus a cardioversion procedure can help restore normal rhythm.
This study looks at how a heart rhythm procedure (cardioversion) affects quality of life in people with persistent atrial fibrillation (AF). It may help you understand whether a specific approach can improve day-to-day symptoms and well-being after treatment.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.